The management of coeliac disease

E T O'Halloran1, M Read, R G Barry

  • 1St. Finbarr's Hospital, Cork.

Irish Medical Journal
|March 9, 1999
PubMed

Insights

Confirming celiac disease in children requires careful evaluation. Gluten challenges and rebiopsies are crucial for accurate diagnosis, even in young children, to avoid misdiagnosis of celiac disease.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Dietary Science

Background:

  • Celiac disease diagnosis in children can be challenging.
  • Initial gluten-free diets are often prescribed based on suspected celiac disease.
  • Accurate diagnosis is essential for long-term management.

Purpose of the Study:

  • To evaluate the long-term diagnostic outcomes of children initially placed on a gluten-free diet.
  • To determine the necessity and timing of gluten challenges and rebiopsies for celiac disease confirmation.
  • To assess the safety and efficacy of earlier gluten challenges in pediatric celiac disease diagnosis.

Main Methods:

  • Longitudinal follow-up of 100 children with suspected celiac disease on a gluten-free diet.
  • Analysis of initial duodenal biopsy findings (villous atrophy).
  • Performance of gluten challenges and repeat biopsies in specific pediatric subgroups.

Main Results:

  • Celiac disease was confirmed in 53 out of 100 children after a mean follow-up of 9.9 years.
  • Nine children under age two, initially showing subtotal villous atrophy, tolerated gluten normally upon challenge.
  • Gluten challenges and rebiopsies are necessary for children over two with less severe initial biopsy changes.

Conclusions:

  • Gluten challenges and rebiopsies are vital for confirming celiac disease in children, especially when initial biopsies are equivocal.
  • Current diagnostic guidelines may benefit from revision regarding the timing of gluten challenges.
  • Earlier gluten challenges in children suspected of celiac disease appear safe and can prevent misdiagnosis.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...